168 related articles for article (PubMed ID: 31080360)
1. New insights into the association between
Xu B; Yuan W; Shi L; Zuo L; Wu XY; Zhang W; Wen Q
Cancer Cell Int; 2019; 19():119. PubMed ID: 31080360
[TBL] [Abstract][Full Text] [Related]
2. The association between three AXIN2 variants and cancer risk.
Dai F; Zhu LJ; Zhang W; Mi YY; Sun HY; Zhang LF; Yue C; Wu XY; Zuo L; Bai Y
J Cell Biochem; 2019 Sep; 120(9):15561-15571. PubMed ID: 31038806
[TBL] [Abstract][Full Text] [Related]
3. New concept of the Axin2 rs2240308 polymorphism and cancer risk: an updated meta-analysis.
Yu Y; Tao Y; Liu L; Yang J; Wang L; Li X; Zhuang X; Chu M
Neoplasma; 2017; 64(2):269-277. PubMed ID: 28043155
[TBL] [Abstract][Full Text] [Related]
4. -148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis.
Zhong A; Pan X; Shi M; Xu H
Onco Targets Ther; 2015; 8():1957-66. PubMed ID: 26251618
[TBL] [Abstract][Full Text] [Related]
5. New insights of the correlation between AXIN2 polymorphism and cancer risk and susceptibility: evidence from 72 studies.
Li X; Li Y; Liu G; Wu W
BMC Cancer; 2021 Apr; 21(1):353. PubMed ID: 33794810
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population.
Kanzaki H; Ouchida M; Hanafusa H; Yano M; Suzuki H; Aoe M; Imai K; Shimizu N; Nakachi K; Shimizu K
Int J Mol Med; 2006 Aug; 18(2):279-84. PubMed ID: 16820935
[TBL] [Abstract][Full Text] [Related]
7. AXIN2 polymorphism and its association with prostate cancer in a Turkish population.
Pinarbasi E; Gunes EG; Pinarbasi H; Donmez G; Silig Y
Med Oncol; 2011 Dec; 28(4):1373-8. PubMed ID: 21069480
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the association between AXIN2 rs2240308 polymorphism and cancer risk.
Gong J; Jiang Y; Hao N; Zhu B; Li Y
Sci Rep; 2015 May; 5():10111. PubMed ID: 25974148
[TBL] [Abstract][Full Text] [Related]
9. The Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a Chinese population.
Liu D; Li L; Yang Y; Liu W; Wu J
Tumour Biol; 2014 Nov; 35(11):10987-91. PubMed ID: 25091576
[TBL] [Abstract][Full Text] [Related]
10. Strong association between lung cancer and the AXIN2 polymorphism.
Gunes EG; Pinarbasi E; Pinarbasi H; Silig Y
Mol Med Rep; 2009; 2(6):1029-35. PubMed ID: 21475939
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variants in the Wingless Antagonist Genes (
Bahl C; Singh N; Behera D; Sharma S
Cancer Biother Radiopharm; 2018 Dec; 33(10):466-477. PubMed ID: 30346805
[No Abstract] [Full Text] [Related]
12. Association study between genetic variations in Axin2 gene and lung cancer risk in North Indian population: A multiple interaction analysis.
Bahl C; Sharma S; Singh N; Behera D
Tumour Biol; 2017 Apr; 39(4):1010428317695533. PubMed ID: 28378643
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis.
Zhao T; Lv J; Zhao J; Nzekebaloudou M
J Exp Clin Cancer Res; 2009 Dec; 28(1):159. PubMed ID: 20035632
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of breast and gastric cancer-associated polymorphisms as potential susceptibility markers for oral clefts in the Brazilian population.
Machado RA; de Freitas EM; de Aquino SN; Martelli DR; Swerts MS; Reis SR; Persuhn DC; Moreira HS; Dias VO; Coletta RD; Martelli-Júnior H
BMC Med Genet; 2017 Apr; 18(1):39. PubMed ID: 28376813
[TBL] [Abstract][Full Text] [Related]
15. HIF-1α 1772 C/T and 1790 G/A polymorphisms are significantly associated with higher cancer risk: an updated meta-analysis from 34 case-control studies.
Yang X; Zhu HC; Zhang C; Qin Q; Liu J; Xu LP; Zhao LJ; Zhang Q; Cai J; Ma JX; Cheng HY; Sun XC
PLoS One; 2013; 8(11):e80396. PubMed ID: 24260383
[TBL] [Abstract][Full Text] [Related]
16. The Association Between
Dai J; Gao H; Xue J; Lin W; Zheng L
Genet Test Mol Biomarkers; 2019 Jun; 23(6):393-400. PubMed ID: 31063404
[No Abstract] [Full Text] [Related]
17. Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.
Yadav A; Gupta A; Yadav S; Rastogi N; Agrawal S; Kumar A; Kumar V; Misra S; Mittal B
Tumour Biol; 2016 Jun; 37(6):8083-95. PubMed ID: 26715268
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.
Chang HY; Liu CY; Lo YL; Chiou SH; Lu KH; Lee MC; Wang YH
J Chin Med Assoc; 2023 Feb; 86(2):207-219. PubMed ID: 36652567
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
Wang X; Goode EL; Fredericksen ZS; Vierkant RA; Pankratz VS; Liu-Mares W; Rider DN; Vachon CM; Cerhan JR; Olson JE; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2101-8. PubMed ID: 18708403
[TBL] [Abstract][Full Text] [Related]
20. Genotypes and Haplotypes in the
Rosales-Reynoso MA; Rosas-Enríquez V; Saucedo-Sariñana AM; Pérez-Coria M; Gallegos-Arreola MP; Salas-González E; Barros-Núñez P; Juárez-Vázquez CI; Flores-Martínez SE; Sánchez-Corona J
Br J Biomed Sci; 2022; 79():10211. PubMed ID: 35996498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
